Specimen validity tests are carried out on a urine drug screen specimen which helps in the process of substitution, dilution and, adulteration.
Substitution- Substitution involves the process of separating water or salt from the specimen and is recognizing by extreme creatinine and any other specific results.
Dilution- In this process, if the drug in the urine is diluted due to the excess of water present in the body below the minimal value, the results can show a false negative.
Adulteration-A contaminant might be added in the sample to affect the testing reagents negatively.
Specimen validity tests are very essential when it comes to urine drug tests. This test supplies disorder analysts with important details about the reliability and accuracy of drug test results, after examining if the specimen received is a valid human urine specimen.
Indicators used during a specimen validity test include:
1) Creatinine
2) Specific Gravity
3) pH
4) Dilute Specimens
5) Substituted Specimen
6) Adulterated Specimen
7) Invalid Specimen
COVID-19 scenario analysis:
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.
Owing to such factors, COVID 19 is expected to have a significant impact on the Specimen Validity Testing market.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:
Increasing consumption of illegal drugs is raising globally, stringent regulations and commandments in drug screening and governments investing to control the drug abuse are propelling the global market during the specimen validity testing. There has also been a considerable amount of rise in the number of laboratories for the screening of drugs and also increasing R & D programs. Additionally, there has been a high demand for carrying out the presumptive tests as the drug abuse population keeps rising. Government support is encouraging the research programs and new opportunities are propelling the market.
Urine drug screening is also helping to upgrade the safety of the patients in the hospital, Awareness is increasing but various government initiatives about the tests and the initiatives are helping in getting acceptance from the population globally. Partnerships and acquisitions of various major key manufactures are also affecting the specimen validity testing market.
On the other hand, emergence and awareness of new and alternative methods are the major challenges faced in the specimen validity testing market.
New product launches and acquisitions to flourish the market:
On May 21st, 2020, Labs@Home is introducing new outpatient management for the transplants of kidneys during the pandemic period.
On April 15th, 2020, Abbott has started a new blood test for the detection of antibodies which indicates if the patient is affected with the novel coronavirus.
Surge in usage in Drug screening laboratories and workplaces applications:
Drug screening laboratories, workplaces, criminal justice, and agencies for law enforcement, drug rehabilitation centers, pain management centers, are the major end-users for the specimen validity testing market. Amongst them, workplaces and drug screening laboratories are the biggest consumers.
Key benefits of the report:
- This study presents the analytical depiction of the global Specimen Validity Testing industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Specimen Validity Testing market share.
- The current market is quantitatively analyzed to highlight the global market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global Specimen Validity Testing market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Specimen Validity Testing Market research report:
- What are the leading market players active in the Specimen Validity Testing market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Specimen Validity Testing Market Report Highlights
| Aspects | Details |
 By Product & Service |
|
 By Type |
|
 By End- User |
|
 By Region |
|
 Key Market Players | ACM Global Laboratories, American Bio Medica Corporation, Quest Diagnostics, Alere Toxicology, Sciteck, Alere, Thermo Fisher, Premier Biotech, LabCorp, Express Diagnostics |
Loading Table Of Content...
